Arrowstreet Capital’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$180M Buy
1,852,709
+733,741
+66% +$64.3M 0.08% 239
2026
Q2
$92.9M Sell
1,118,968
-44,219
-4% -$2.4M 0.04% 371
2026
Q1
$44.9M Buy
1,163,187
+806,007
+226% +$33.5M 0.02% 518
2025
Q4
$16.6M Buy
357,180
+151,785
+74% +$7.31M 0.01% 792
2025
Q3
$10.1M Buy
+205,395
New +$10.7M 0.01% 950

Other funds holding HNGE

Arrowstreet Capital's HNGE Position: Q3 2026 in Review

Arrowstreet Capital increased its Hinge Health (HNGE) stake by 66% in Q3 2026, buying an estimated $64.3M and bringing the position to 1,852,709 shares worth $180M. The position accounts for 0.08% of the portfolio, ranked #239.

Arrowstreet Capital first reported a position in HNGE in Q3 2025 and has held it in 5 quarters since. 368 funds tracked by Wall St. Rank hold HNGE as of Q3 2026.

  • Arrowstreet Capital held 1,852,709 shares of Hinge Health worth $180M as of Q3 2026.
  • Arrowstreet Capital bought 733,741 Hinge Health shares in Q3 2026, an estimated $64.3M.
  • Hinge Health made up 0.08% of Arrowstreet Capital's portfolio in Q3 2026, its #239 holding.
  • Arrowstreet Capital first reported a position in Hinge Health in Q3 2025 and has held it in 5 quarters since.
  • 368 funds tracked by Wall St. Rank held Hinge Health as of Q3 2026.

Based on Arrowstreet Capital's 13F filing for Q3 2026, filed 13 Nov 2026.